TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/tso3-inc-tos-financial-n-strategic-swot-analysis-review_en.gif)
TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
TSO3 Inc (TSO3) design, develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.
TSO3 Inc Key Recent Developments
Sep 26,2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
Aug 12,2019: TSO3 reports second quarter 2019 results
May 06,2019: TSO3 reports first quarter 2019 results
Apr 02,2019: TSO3 announces changes to the Board of Directors
Mar 27,2019: TSO3 reports fourth quarter and full year 2018 results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
TSO3 Inc (TSO3) design, develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.
TSO3 Inc Key Recent Developments
Sep 26,2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
Aug 12,2019: TSO3 reports second quarter 2019 results
May 06,2019: TSO3 reports first quarter 2019 results
Apr 02,2019: TSO3 announces changes to the Board of Directors
Mar 27,2019: TSO3 reports fourth quarter and full year 2018 results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
TSO3 Inc - Key Facts
TSO3 Inc - Key Employees
TSO3 Inc - Key Employee Biographies
TSO3 Inc - Major Products and Services
TSO3 Inc - History
TSO3 Inc - Company Statement
TSO3 Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
TSO3 Inc - Business Description
TSO3 Inc - SWOT Analysis
SWOT Analysis - Overview
TSO3 Inc - Strengths
TSO3 Inc - Weaknesses
TSO3 Inc - Opportunities
TSO3 Inc - Threats
TSO3 Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
TSO3 Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
TSO3 Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
Aug 12, 2019: TSO3 reports second quarter 2019 results
May 06, 2019: TSO3 reports first quarter 2019 results
Apr 02, 2019: TSO3 announces changes to the Board of Directors
Mar 27, 2019: TSO3 reports fourth quarter and full year 2018 results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
TSO3 Inc - Key Facts
TSO3 Inc - Key Employees
TSO3 Inc - Key Employee Biographies
TSO3 Inc - Major Products and Services
TSO3 Inc - History
TSO3 Inc - Company Statement
TSO3 Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
TSO3 Inc - Business Description
TSO3 Inc - SWOT Analysis
SWOT Analysis - Overview
TSO3 Inc - Strengths
TSO3 Inc - Weaknesses
TSO3 Inc - Opportunities
TSO3 Inc - Threats
TSO3 Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
TSO3 Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
TSO3 Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
Aug 12, 2019: TSO3 reports second quarter 2019 results
May 06, 2019: TSO3 reports first quarter 2019 results
Apr 02, 2019: TSO3 announces changes to the Board of Directors
Mar 27, 2019: TSO3 reports fourth quarter and full year 2018 results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
TSO3 Inc, Key Facts
TSO3 Inc, Key Employees
TSO3 Inc, Key Employee Biographies
TSO3 Inc, Major Products and Services
TSO3 Inc, History
TSO3 Inc, Subsidiaries
TSO3 Inc, Key Competitors
TSO3 Inc, Ratios based on current share price
TSO3 Inc, Annual Ratios
TSO3 Inc, Annual Ratios (Cont...1)
TSO3 Inc, Interim Ratios
TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
TSO3 Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
TSO3 Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
TSO3 Inc, Key Facts
TSO3 Inc, Key Employees
TSO3 Inc, Key Employee Biographies
TSO3 Inc, Major Products and Services
TSO3 Inc, History
TSO3 Inc, Subsidiaries
TSO3 Inc, Key Competitors
TSO3 Inc, Ratios based on current share price
TSO3 Inc, Annual Ratios
TSO3 Inc, Annual Ratios (Cont...1)
TSO3 Inc, Interim Ratios
TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
TSO3 Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
TSO3 Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
TSO3 Inc, Performance Chart (2014 - 2018)
TSO3 Inc, Ratio Charts
TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
TSO3 Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Steris Corp
Olympus Corporation of the Americas
Johnson & Johnson
Getinge AB
Custom Ultrasonics Inc
Cantel Medical Corp
TSO3 Inc, Performance Chart (2014 - 2018)
TSO3 Inc, Ratio Charts
TSO3 Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
TSO3 Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Steris Corp
Olympus Corporation of the Americas
Johnson & Johnson
Getinge AB
Custom Ultrasonics Inc
Cantel Medical Corp